BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23341579)

  • 21. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice.
    Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1995-2003. PubMed ID: 9351364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of ACAT1 Attenuates Atherosclerosis Aggravated by Loss of NCEH1 in Bone Marrow-Derived Cells.
    Yamazaki H; Takahashi M; Wakabayashi T; Sakai K; Yamamuro D; Takei A; Takei S; Nagashima S; Yagyu H; Sekiya M; Ebihara K; Ishibashi S
    J Atheroscler Thromb; 2019 Mar; 26(3):246-259. PubMed ID: 30282838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells.
    Bavendiek U; Zirlik A; LaClair S; MacFarlane L; Libby P; Schönbeck U
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1244-9. PubMed ID: 15746436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44-deficiency on hematopoietic cells limits T-cell number but does not protect against atherogenesis in LDL receptor-deficient mice.
    Sjöberg S; Eriksson EE; Tivesten A; Carlsson A; Klasson A; Levin M; Borén J; Krettek A
    Atherosclerosis; 2009 Oct; 206(2):369-74. PubMed ID: 19345948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic retinoid Am80 reduces scavenger receptor expression and atherosclerosis in mice by inhibiting IL-6.
    Takeda N; Manabe I; Shindo T; Iwata H; Iimuro S; Kagechika H; Shudo K; Nagai R
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1177-83. PubMed ID: 16484594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice.
    Guo J; Bot I; de Nooijer R; Hoffman SJ; Stroup GB; Biessen EA; Benson GM; Groot PH; Van Eck M; Van Berkel TJ
    Cardiovasc Res; 2009 Feb; 81(2):278-85. PubMed ID: 19015136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoting macrophage survival delays progression of pre-existing atherosclerotic lesions through macrophage-derived apoE.
    Bouchareychas L; Pirault J; Saint-Charles F; Deswaerte V; Le Roy T; Jessup W; Giral P; Le Goff W; Huby T; Gautier EL; Lesnik P
    Cardiovasc Res; 2015 Oct; 108(1):111-23. PubMed ID: 26092098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes.
    Babaev VR; Runner RP; Fan D; Ding L; Zhang Y; Tao H; Erbay E; Görgün CZ; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1283-90. PubMed ID: 21474828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype.
    Kanters E; Gijbels MJ; van der Made I; Vergouwe MN; Heeringa P; Kraal G; Hofker MH; de Winther MP
    Blood; 2004 Feb; 103(3):934-40. PubMed ID: 14512319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophages, inflammation, and atherosclerosis.
    Linton MF; Fazio S
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S35-40. PubMed ID: 14704742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming macrophages to an anti-inflammatory phenotype by helminth antigens reduces murine atherosclerosis.
    Wolfs IM; Stöger JL; Goossens P; Pöttgens C; Gijbels MJ; Wijnands E; van der Vorst EP; van Gorp P; Beckers L; Engel D; Biessen EA; Kraal G; van Die I; Donners MM; de Winther MP
    FASEB J; 2014 Jan; 28(1):288-99. PubMed ID: 24043262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress.
    Tietge UJ; Pratico D; Ding T; Funk CD; Hildebrand RB; Van Berkel T; Van Eck M
    J Lipid Res; 2005 Aug; 46(8):1604-14. PubMed ID: 15897607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions.
    Tang EH; Shimizu K; Christen T; Rocha VZ; Shvartz E; Tesmenitsky Y; Sukhova G; Shi GP; Libby P
    Cardiovasc Res; 2011 Jan; 89(1):234-43. PubMed ID: 20736236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.
    Kanters E; Pasparakis M; Gijbels MJ; Vergouwe MN; Partouns-Hendriks I; Fijneman RJ; Clausen BE; Förster I; Kockx MM; Rajewsky K; Kraal G; Hofker MH; de Winther MP
    J Clin Invest; 2003 Oct; 112(8):1176-85. PubMed ID: 14561702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice.
    Kennedy DJ; Kuchibhotla SD; Guy E; Park YM; Nimako G; Vanegas D; Morton RE; Febbraio M
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1481-7. PubMed ID: 19608973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.
    Collins AR; Gupte AA; Ji R; Ramirez MR; Minze LJ; Liu JZ; Arredondo M; Ren Y; Deng T; Wang J; Lyon CJ; Hsueh WA
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2839-46. PubMed ID: 23023374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepcidin Deficiency Protects Against Atherosclerosis.
    Malhotra R; Wunderer F; Barnes HJ; Bagchi A; Buswell MD; O'Rourke CD; Slocum CL; Ledsky CD; Peneyra KM; Sigurslid H; Corman B; Johansson KB; Rhee DK; Bloch KD; Bloch DB
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):178-187. PubMed ID: 30587002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.